Table 3.

Prognostic impact of WT1-mRNA expression on outcome of patients with MDS in multivariate analysis

	Progression-free survival HR (95% CI)	p-value	Overall survival HR (95% CI)	p-value
WT1-mRNA expression status (<50 vs. >50a)	0.239 (0.152–0.566)	0.0001	0.486 (0.208–1.136)	0.096
IPSS-R (very low/low vs. int/high/very high)	0.640 (0.325–1.258)	0.196	1.222 (0.875–1.705)	0.240

^aCopies/10⁴ ABL copies